Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

3 Stocks That Every 20-Year-Old Should Buy Today

By Josh Enomoto, InvestorPlace Contributor

When you’re just starting out in adult life, you have time on your side. Use it to your advantage with these stocks for young investors.

3 Boring Stocks That You Should Buy and Hold Forever

By Josh Enomoto, InvestorPlace Contributor

While these boring stocks might not endear themselves to extreme gamblers, they offer relevancy and upside potential.

7 Little-Known Stocks to Buy Now Before They Become the Next Big Thing

By Josh Enomoto, InvestorPlace Contributor

Although people might not readily recognize these little-known stocks, they offer surprisingly robust upside potential.

5 Investors Betting Big on Carnival (CCL) Stock

By Josh Enomoto, InvestorPlace Contributor

With an analyst upgrade at Jefferies, Carnival continues to enjoy fuel for its mercurial rally, sending CCL stock above a wall of worries.

Why Is Baudax Bio (BXRX) Stock Up 130% Today?

By Josh Enomoto, InvestorPlace Contributor

Although Baudax Bio soared on Friday following its acquisition of Teralmmune, BXRX stock remains an extremely speculative venture.

Load More